Scarica l'app Stockscreener
22.00
3.53%
0.75
Pre-mercato:
22.00
Precedente Chiudi:
$21.25
Aprire:
$21.51
Volume 24 ore:
588.33K
Relative Volume:
2.60
Capitalizzazione di mercato:
$752.62M
Reddito:
-
Utile/perdita netta:
$-81.05M
Rapporto P/E:
-8.3867
EPS:
-2.6232
Flusso di cassa netto:
$-68.97M
1 W Prestazione:
+7.84%
1M Prestazione:
+3.29%
6M Prestazione:
-25.58%
1 anno Prestazione:
+13.34%
Intervallo 1D:
$21.01
$22.42
Intervallo di 1 settimana:
$19.80
$22.42
Portata 52W:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Nome
Arrivent Biopharma Inc
Settore
Industria
Telefono
240-780-6356
Indirizzo
18 CAMPUS BLVD., NEWTOWN SQUARE
Confronta AVBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
22.00 | 705.81M | 0 | -81.05M | -68.97M | -2.6232 |
|
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-20 | Iniziato | B. Riley Securities | Buy |
| 2025-03-10 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-20 | Iniziato | Citigroup | Buy |
| 2024-02-20 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | Jefferies | Buy |
Mostra tutto
Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of “Buy” by Analysts - Defense World
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MyChesCo
BNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,327 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Promising Outlook for ArriVent BioPharma: Buy Rating Justified by Upcoming EGFR PACC Mutant NSCLC Program Updates - TipRanks
Deutsche Bank AG Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.5% – Here’s What Happened - Defense World
Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jones Trading - Defense World
JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with - GuruFocus
ArriVent BioPharma (AVBP) Coverage Initiated with 'Buy' Rating | - GuruFocus
JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with Optimistic Outlook | AVBP Stock News - GuruFocus
Northern Trust Corp Purchases 10,498 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN
Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo
When the Price of (AVBP) Talks, People Listen - news.stocktradersdaily.com
Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $40.00 - Defense World
Price T Rowe Associates Inc. MD Has $293,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
B. Riley Lifts Earnings Estimates for ArriVent BioPharma - Defense World
Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors - MyChesCo
ArriVent BioPharma (AVBP) Receives Price Target Increase by HC W - GuruFocus
Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AV - GuruFocus
ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AVBP Stock News - GuruFocus
Voya Investment Management LLC Acquires Shares of 8,373 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Tower Research Capital LLC TRC Has $43,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView
ArriVent Biopharma (AVBP) Projects Financial Stability Through 2 - GuruFocus
ArriVent Biopharma (AVBP) Projects Financial Stability Through 2026 | AVBP Stock News - GuruFocus
ArriVent (AVBP) Advances Oncology Pipeline with Key Milestones Ahead | AVBP Stock News - GuruFocus
ArriVent BioPharma Reports First Quarter 2025 Financial Results - The Manila Times
ArriVent BioPharma (AVBP) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (AVBP) - news.stocktradersdaily.com
Arrivent Biopharma Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World
Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World
Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma Appoints Dr. Merdad Parsey to Board of Directors - MyChesCo
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - The Manila Times
Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MyChesCo
ArriVent BioPharma appoints new board member By Investing.com - Investing.com South Africa
ArriVent BioPharma appoints new board member - Investing.com Australia
ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - citybiz
ArriVent BioPharma (AVBP) Strengthens Leadership with New Board - GuruFocus
Arrivent Biopharma Inc Azioni (AVBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):